BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28842558)

  • 1. HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells.
    Wang WF; Yan L; Liu Z; Liu LX; Lin J; Liu ZY; Chen XP; Zhang W; Xu ZZ; Shi T; Li JM; Zhao YL; Meng G; Xia Y; Li JY; Zhu J
    Nat Commun; 2017 Aug; 8(1):363. PubMed ID: 28842558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.
    Xia Y; Xu-Monette ZY; Tzankov A; Li X; Manyam GC; Murty V; Bhagat G; Zhang S; Pasqualucci L; Visco C; Dybkaer K; Chiu A; Orazi A; Zu Y; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Westin J; Fowler N; Miranda RN; Ok CY; Li Y; Li J; Medeiros LJ; Young KH
    Leukemia; 2017 Mar; 31(3):625-636. PubMed ID: 27568520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation.
    Yang H; Qiu Q; Gao B; Kong S; Lin Z; Fang D
    J Exp Med; 2014 Nov; 211(12):2467-79. PubMed ID: 25366967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aiolos collaborates with Blimp-1 to regulate the survival of multiple myeloma cells.
    Hung KH; Su ST; Chen CY; Hsu PH; Huang SY; Wu WJ; Chen MJ; Chen HY; Wu PC; Lin FR; Tsai MD; Lin KI
    Cell Death Differ; 2016 Jul; 23(7):1175-84. PubMed ID: 26823144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive CD40 Signaling Calibrates Differentiation Outcomes in Responding B Cells via Multiple Molecular Pathways.
    Basu S; Kaw S; D'Souza L; Vaidya T; Bal V; Rath S; George A
    J Immunol; 2016 Aug; 197(3):761-70. PubMed ID: 27342845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel in vivo model for studying conditional dual loss of BLIMP-1 and p53 in B-cells, leading to tumor transformation.
    Sacco A; Kawano Y; Moschetta M; Zavidij O; Huynh D; Reagan M; Mishima Y; Manier S; Park J; Morgan E; Takagi S; Wong KK; Carrasco R; Ghobrial IM; Roccaro AM
    Am J Hematol; 2017 Aug; 92(8):E138-E145. PubMed ID: 28474779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.
    Hagner PR; Man HW; Fontanillo C; Wang M; Couto S; Breider M; Bjorklund C; Havens CG; Lu G; Rychak E; Raymon H; Narla RK; Barnes L; Khambatta G; Chiu H; Kosek J; Kang J; Amantangelo MD; Waldman M; Lopez-Girona A; Cai T; Pourdehnad M; Trotter M; Daniel TO; Schafer PH; Klippel A; Thakurta A; Chopra R; Gandhi AK
    Blood; 2015 Aug; 126(6):779-89. PubMed ID: 26002965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blimp-1 is a tumor suppressor gene in lymphoid malignancies.
    Hangaishi A; Kurokawa M
    Int J Hematol; 2010 Jan; 91(1):46-53. PubMed ID: 20047096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1.
    Ramkumar C; Cui H; Kong Y; Jones SN; Gerstein RM; Zhang H
    Nat Commun; 2013; 4():2598. PubMed ID: 24121673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress on B lymphocyte-induced maturation protein 1 and its relationship with the development of lymphoma].
    Liu ZY; Li JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1623-6. PubMed ID: 24370060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline.
    Pulvino M; Chen L; Oleksyn D; Li J; Compitello G; Rossi R; Spence S; Balakrishnan V; Jordan C; Poligone B; Casulo C; Burack R; Shapiro JL; Bernstein S; Friedberg JW; Deshaies RJ; Land H; Zhao J
    Oncotarget; 2015 Jun; 6(17):14796-813. PubMed ID: 26142707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.
    Pasqualucci L; Compagno M; Houldsworth J; Monti S; Grunn A; Nandula SV; Aster JC; Murty VV; Shipp MA; Dalla-Favera R
    J Exp Med; 2006 Feb; 203(2):311-7. PubMed ID: 16492805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSP70 mediates degradation of the p65 subunit of nuclear factor κB to inhibit inflammatory signaling.
    Tanaka T; Shibazaki A; Ono R; Kaisho T
    Sci Signal; 2014 Dec; 7(356):ra119. PubMed ID: 25515536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma.
    Yang Y; Shaffer AL; Emre NC; Ceribelli M; Zhang M; Wright G; Xiao W; Powell J; Platig J; Kohlhammer H; Young RM; Zhao H; Yang Y; Xu W; Buggy JJ; Balasubramanian S; Mathews LA; Shinn P; Guha R; Ferrer M; Thomas C; Waldmann TA; Staudt LM
    Cancer Cell; 2012 Jun; 21(6):723-37. PubMed ID: 22698399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells.
    O'Hayre M; Inoue A; Kufareva I; Wang Z; Mikelis CM; Drummond RA; Avino S; Finkel K; Kalim KW; DiPasquale G; Guo F; Aoki J; Zheng Y; Lionakis MS; Molinolo AA; Gutkind JS
    Oncogene; 2016 Jul; 35(29):3771-80. PubMed ID: 26616858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.
    Nie K; Zhang T; Allawi H; Gomez M; Liu Y; Chadburn A; Wang YL; Knowles DM; Tam W
    Am J Pathol; 2010 Sep; 177(3):1470-9. PubMed ID: 20651244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens.
    Young RM; Wu T; Schmitz R; Dawood M; Xiao W; Phelan JD; Xu W; Menard L; Meffre E; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Staudt LM
    Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13447-54. PubMed ID: 26483459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism.
    Aoki T; Shimada K; Sakamoto A; Sugimoto K; Morishita T; Kojima Y; Shimada S; Kato S; Iriyama C; Kuno S; Harada Y; Tomita A; Hayakawa F; Kiyoi H
    Oncotarget; 2017 Feb; 8(8):13085-13098. PubMed ID: 28055963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of heat-induced apoptosis by Mcl-1 degradation and its inhibition by Hsp70.
    Stankiewicz AR; Livingstone AM; Mohseni N; Mosser DD
    Cell Death Differ; 2009 Apr; 16(4):638-47. PubMed ID: 19148187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ON 01910.Na inhibits growth of diffuse large B-cell lymphoma by cytoplasmic sequestration of sumoylated C-MYB/TRAF6 complex.
    Dai YH; Hung LY; Chen RY; Lai CH; Chang KC
    Transl Res; 2016 Sep; 175():129-143.e13. PubMed ID: 27150054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.